HENRY E. PAUL
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Microbial Natural Products and Biosynthesis 3
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Mary F. Paul (9 shared papers)J.D. Taylor (1 shared paper)George A. Everett (1 shared paper)Melvin J. Bryson (1 shared paper)James A. Buzard (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Experimental Biology and Medicine (2 papers)Journal of Medicinal Chemistry (1 paper)Life Sciences (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United States
In The Last Decade
HENRY E. PAUL
13 papers receiving 294 citations
Peers
Comparison fields: 5 of 68
- Toxicology 54
- Pharmacology 82
- Pharmaceutical Science 48
- Reproductive Medicine 49
- Cancer Research 47
Countries citing papers authored by HENRY E. PAUL
This map shows the geographic impact of HENRY E. PAUL's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HENRY E. PAUL with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HENRY E. PAUL more than expected).
Fields of papers citing papers by HENRY E. PAUL
This network shows the impact of papers produced by HENRY E. PAUL. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HENRY E. PAUL. The network helps show where HENRY E. PAUL may publish in the future.
Co-authors
The 5 scholars most cited alongside HENRY E. PAUL, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1967 | 71 | |
| 2 | 1951 | 57 | |
| 3 | 1964 | 55 | |
| 4 | 1960 | 54 | |
| 5 | 1953 | 44 | |
| 6 | 1954 | 41 | |
| 7 | Studies on the distribution and excretion of certain nitrofurans. | 1960 | 39 |
| 8 | 1951 | 27 | |
| 9 | 1952 | 18 | |
| 10 | 1952 | 14 | |
| 11 | 1952 | 12 | |
| 12 | 1951 | 4 | |
| 13 | 1965 | 3 | |
| 14 | 1953 | 2 |
About HENRY E. PAUL
HENRY E. PAUL is a scholar working on Pharmacology, Pharmacology, Toxicology, Pharmaceutical Science and Reproductive Medicine, having authored 14 papers that have together received 441 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Microbial Natural Products and Biosynthesis (3 papers), Microbial metabolism and enzyme function (2 papers), Drug Solubulity and Delivery Systems (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Sperm and Testicular Function (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Toxicology (54 citations), Pharmacology (82 citations), Pharmaceutical Science (48 citations), Reproductive Medicine (49 citations) and Cancer Research (47 citations). HENRY E. PAUL has collaborated with scholars based in United States. Frequent co-authors include Mary F. Paul, J.D. Taylor, George A. Everett, Melvin J. Bryson and James A. Buzard. Their work appears in journals such as Journal of Biological Chemistry, Experimental Biology and Medicine, Journal of Medicinal Chemistry, Life Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.